Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Cook David N
Relationship:   SVP, Chief Scientific ...
City:   Concord
State:   CA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   232,740    

Indirect Shares

  0      
Direct Value   $242,039    

Indirect Value

  $0      
Total Shares   232,740      
Total Value   $242,039      


Cerus Corp
 $71,014 Seres Therapeutics, Inc.
 $171,025 Forma Therapeutics Holdings, Inc.,
 $0 Cerus Corp
 $71,014 Seres Therapeutics, Inc.
 $171,025 Forma Therapeutics Holdings, Inc.,
 $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    0    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Cerus Corp CERS Vice President, R & D 2007-01-05 43,836 2004-03-19 0    Premium*  
            Seres Therapeutics, Inc. MCRB See Remarks 2019-01-26 147,435 0    Premium*  
            Forma Therapeutics Holdings, Inc., FMTX SVP, Chief Scientific ... 2022-02-28 41,469 2021-02-26 0    Premium*  
* Premium Members only  

Records found :    17         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
FMTX Forma Therapeutics Holdin... SVP, Chief Scientific Officer   •       –      –    2022-02-28 4 A $0.00 $0 D/D 25,000 41,469 0 -
FMTX Forma Therapeutics Holdin... SVP, Chief Scientific Officer   •       –      –    2022-02-23 4 S $9.78 $34,524 D/D (3,531) 16,469 0 -
FMTX Forma Therapeutics Holdin... SVP, Chief Scientific Officer   •       –      –    2021-02-26 4 A $0.00 $0 D/D 20,000 20,000 0 -
MCRB Seres Therapeutics, Inc. See Remarks   •       –      –    2019-01-26 4 OE $0.00 $0 D/D 7,500 147,435 0 -
MCRB Seres Therapeutics, Inc. See Remarks   •       –      –    2018-01-26 4 S $11.02 $19,153 D/D (1,738) 139,935 0 -
MCRB Seres Therapeutics, Inc. See Remarks   •       –      –    2018-01-26 4 OE $0.00 $0 D/D 5,000 141,673 0 -
MCRB Seres Therapeutics, Inc. Chief Scientific Officer & EVP   •       –      –    2016-06-02 4 AS $31.00 $248,000 D/D (8,000) 136,673 0 -
MCRB Seres Therapeutics, Inc. Chief Scientific Officer & EVP   •       –      –    2016-06-01 4 AS $29.43 $470,880 D/D (16,000) 144,673 0 -
MCRB Seres Therapeutics, Inc. Chief Scientific Officer & EVP   •       –      –    2016-04-07 4 AS $31.00 $248,000 D/D (8,000) 160,673 0 -
MCRB Seres Therapeutics, Inc. Chief Scientific Officer & EVP   •       –      –    2016-04-04 4 AS $28.00 $224,000 D/D (8,000) 168,673 0 -
MCRB Seres Therapeutics, Inc. Chief Scientific Officer & EVP   •       –      –    2016-04-01 4 AS $25.74 $1,371,586 D/D (53,000) 176,673 0 -
MCRB Seres Therapeutics, Inc. See Remarks   •       –      –    2015-06-26 4 A $0.00 $0 D/D 45,454 229,673 0 -
MCRB Seres Therapeutics, Inc. CSO and EVP of R&DOfficer   •       –      –    2015-06-25 3 IO $0.00 $0 D/D 0 184,219 -
CERS Cerus Corp Vice President, R & D   •       –      –    2007-01-05 4 A $0.00 $0 D/D 5,970 43,836 0 -
CERS Cerus Corp Vice President, R & D   •       –      –    2006-04-03 4 A $0.00 $0 D/D 50 37,916 -
CERS Cerus Corp officerTitle   •       –      –    2006-01-09 4 A $0.00 $0 D/D 4,033 37,866 -
CERS Cerus Corp Vice President, R & D   •       –      –    2004-03-19 4 A $0.00 $0 D/D 11,500 33,833 -

  17  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed